growth opportunity?

$Can-Fite BioPharma (CANF.US)$ jumped in here late last year and don't regret it 😁 With a target of 10, and coming off a historical low of 1.29 in Dec, it made sense given recent strong news announcements and more than one drug in the pipeline. Its had daily volatility but overall stronger growth since the low, sitting at 1.75 it has massive potential. NFA and DYDD